Merck’s at-home antiviral COVID-19 pill gets US authorization
The US on Thursday authorized Merck & Co’s antiviral pill for COVID-19 for certain high-risk adult patients, a day after giving the go-ahead to a similar but more effective treatment from Pfizer Inc.
Merck’s drug, molnupiravir,…
Read More...
Read More...